MDT - J&J releases positive data on PFA system for arrhythmia
2024-02-05 16:08:41 ET
More on Johnson & Johnson
- Johnson & Johnson: Positioned To Receive Benefits Of Heavy R&D Investments
- Johnson & Johnson: Balance Growth Between MedTech And Medicine, Initiate With A 'Buy'
- Johnson & Johnson 2023 Q4 - Results - Earnings Call Presentation
- Johnson & Johnson succeeds in trials for autoimmune drug
- Pharma giants turn to China in search of targeted cancer drugs